Search
Search Results
##search.searchResults.foundPlural##
-
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1013PDF: 371HTML: 208 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3603PDF: 2527HTML: 1504 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3124PDF: 922HTML: 2060 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2323PDF: 1654HTML: 281 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1561PDF: 891HTML: 988figures: 190table 1: 190table2: 188table3: 191 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7702PDF: 2451HTML: 1742Table 1.: 218Table 2.: 229Table 3.: 212Table 4.: 211 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2648PDF: 1633HTML: 2374Table1: 196 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1619PDF: 407HTML: 218 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1142PDF: 503HTML: 245 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1576PDF: 801HTML: 220 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1651PDF: 597HTML: 236 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1396PDF: 858HTML: 139 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2157PDF: 1011HTML: 4079Cover Letter: 226Figure 1: 238Figure 2: 235Table 1: 208 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4433PDF: 1731HTML: 1057 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1426PDF: 832HTML: 3124 -
Skin Involvement in Primary Systemic Amyloidosis
1667PDF: 902HTML: 4388Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 184Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 158Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 181 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1888PDF: 729HTML: 2122Untitled: 225Untitled: 158Untitled: 177Untitled: 161Untitled: 169Untitled: 184Untitled: 191 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3998PDF: 1317HTML: 2275 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1540PDF: 557HTML: 755 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1322PDF: 477HTML: 18617Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2231PDF: 2065HTML: 200 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
854PDF: 834HTML: 132 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1206PDF: 771HTML: 1400Figure 1: 195Figure 2: 197 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1277PDF: 547HTML: 231







